For instance, the presence of type 2 diabetes mellitus (T2DM) and IGF-1 levels > 1.5 × ULN motivate to PEGV shift after SRLs resistance (86% each), and the recurrence of previously controlled headaches is a concern for 83% of the panelists. This evidence concerns the gene IGF1 and diabetes mellitus.